Background. Patients with chronic renal failure have an increased risk of tuberculosis (TB). This occurs with much higher frequency within the ®rst 12 months of initiating dialysis and is usually extrapulmonary in nature. Patients most at risk are those from susceptible ethnic groups, especially the Indian subcontinent. Peritoneal TB, otherwise relatively uncommon, has emerged as an important form of TB in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Methods. All cases of peritoneal TB occurring at our institution in patients undergoing CAPD over a 13 year period were identi®ed and analysed. Results. Eight cases were identi®ed, of which seven were non-Caucasian. These patients' characteristics and outcomes are presented. All were undergoing CAPD and most developed TB within 12 months of initiating dialysis. All presented with fever, but symptoms and signs were indistinguishable from bacterial peritonitis. Six were culture-positive, mainly from peritoneal dialysis¯uid, but only two cases proved smear-positive. All were treated with standard anti-tuberculous chemotherapy. Three went on to permanent haemodialysis as a result of peritonitis and three have died, one of these as a result of TB. Conclusions. Peritoneal TB, whilst otherwise relatively uncommon, is an important manifestation of TB in CAPD patients and usually develops soon after commencing dialysis. The reasons for this are unknown and require further research.
Introduction
Patients with chronic renal failure have an increased incidence of tuberculosis (TB) compared to those with normal renal function, which may be due to a decrease in cellular immunity w1±5x. Patients from susceptible ethnic groups are most at risk w6x. Previous studies have found TB to be predominantly extrapulmonary in dialysis patients and to occur soon after initiation of renal replacement therapy w2,3,6±9x. Peritoneal TB, which is seldom seen in patients with normal renal function, is a particular problem in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) w10x. The Manchester Royal In®rmary (MRI) has a large renal unit with dialysis and transplant facilities and a catchment population which includes a high proportion of non-Caucasians, especially from the Indian subcontinent.
The aim of this study was to identify and describe the clinical characteristics and outcomes of such patients seen at one hospital.
Subjects and methods
We examined the case records of patients with peritoneal TB undergoing CAPD, over a 13-year period between 1986 and 1999. Cases were identi®ed by three methods: medical outpatient coding, microbiology records, and the respiratory unit TB database. All patients were treated at the same institution (MRI) for both renal failure and TB.
Results
Fourteen cases of TB occurring in CAPD patients including eight (57%) patients with peritoneal TB were identi®ed over the study period. The clinical characteristics of these eight patients are illustrated in Table 1 . Only one of the eight patients was Caucasian (patient 8), with six of the eight originating from the Indian subcontinent. Diabetes was present in three patients, and one (patient 7) was taking maintenance prednisolone following a failed previous renal transplant. Patient 8 had previous occupational exposure to bovine TB as a public health inspector of meat carcasses. In ®ve cases TB developed within 12 months or less after the initiation of dialysis. Clinical presentation was indistinguishable from non-mycobacterial CAPD peritonitis (Table 1 ). All patients presented with fever as one of their symptoms. Chest X-rays did not show speci®c features of TB although pleural effusions were present in two cases. Peritoneal¯uid was smear-positive for acid-fast bacilli in only one case but culture-positive in six of the eight. A peritoneal biopsy specimen was sent for histology in four cases, of which three demonstrated granulomata and one proved both smear-and culture-positive.
Treatment was given with a combination of isoniazid (200±300 mguday), rifampicin (450±600 mguday), and pyrazinamide (1.5±2 guday), plus pyridoxine (10 mguday) for a total of 6±12 months. Pyrazinamide was stopped after 0.5±6 months. Patient 1 suffered a number of side-effects 2 weeks into anti-tuberculous therapy, including confusion, drowsiness, and twitching, which disappeared when treatment was stopped. These symptoms did not reappear when treatment was restarted, but diarrhoea and vomiting then occurred, necessitating a switch to intravenous anti-tuberculous therapy until the symptoms abated after 2 weeks. Patient 4 developed a drug-fever, thought to be due to isoniazid.
Five of the eight patients were successfully treated and cured and one other (patient 6) is approaching the end of treatment. Three (patients 2,3 and 8) were switched to haemodialysis as a result of their peritoneal TB: in patient 2, TB in itself was deemed an indication for catheter removal (although we subsequently changed this policy), patient 3 suffered progressive loss of ultra®ltration, and patient 8 had persistent peritonitis with cloudy bags and abdominal pain. Patients 2 and 4 have since died of causes unrelated to TB. Patient 7 died from acute smallbowel obstruction secondary to adhesions which were attributed to TB.
Discussion
Peritoneal TB, an otherwise relatively uncommon condition, developed in eight patients over the 13-year study period, representing over half the cases of TB in our CAPD population. Data from the North West Region Public Health Department (Dr M. Painter, personal communication, 22u12u99) showed that overall peritoneal TB accounted for only 1.4% of the total cases of TB noti®ed in Manchester over the same time period. Other investigators have also noted this form of TB to be prominent in CAPD patients w10,11x. However, the reasons for the predominance of this site are obscure. No cases of peritoneal TB have occurred as yet in any of our haemodialysis patients.
Over the 13-year study period approximately 1000 new patients have commenced dialysis on our renal unit, of which about 12% are of Asian origin. Since 12u14 of our dialysis patients with TB were Asian this means that 12u120 (10%) Asian patients going on to dialysis developed TB. The incidence of TB in the UK is up to 30 times higher in the Asian community (114.7u100 000 (Indian), 120.1u100 000 (Pakistani) compared to 4.3u100 000 in the white population) w12x, occurring mostly in immigrants whose primary infection occurred whilst resident in their country of origin. Approximately 70% of new immigrants to the UK from the Indian subcontinent aged 15±29 years old have a positive tuberculin skin test w13x, and our institution has a catchment area with a large Asian (mainly Pakistani) population. It is, therefore, perhaps not surprising that most of our patients on dialysis with TB are Asian. In addition, extrapulmonary TB accounts for proportionally more cases of TB in Indian subcontinent (38%) than in Caucasian patients (21%) w12x.
Patients with chronic renal failure have an increased risk of developing TB, possibly due to decreased cellular immunity w1±4,6,10x. Malnutrition may also be responsible in some cases w5x. Most studies which have reviewed TB in chronic renal failure, though, have been in patients undergoing regular haemodialysis w3,7,8x. Reactivation, which is presumably what this tuberculous peritonitis represents in these patients, most commonly occurs in the lungs. Its occurrence in the peritoneum argues strongly that local derangements in the intraperitoneal immune defence, linked to the process of CAPD, are responsible. Defects of immune function in the peritoneal cavity in CAPD include reduced phagocytosis by macrophages, reduced cytokine production, and a signi®cant reduction in the total number of peritoneal lymphocytes w14x. These defects occur possibly as a result of the high lactate and hydrogen ion concentration of the dialysate; a dilutional effect of the relatively large volumes of dialysate used also results in a reduction in macrophageuorganism interaction.
As in previous studies, we have found that TB tends to develop soon after initiating dialysis. i.e. usually within 12 months, and frequently occurs in extrapulmonary sites w2,3,6±9x. This seems to be true of both haemodialysis and CAPD, but again the reasons are unknown: correction of uraemia appears to trigger reactivation of TB (most TB in adult non-Caucasians is reactivated, not primary) w15x. The reason for the relatively early development of TB and its usual predominance for lymph nodes may be related to the improvement in lymphocyte response seen after dialysis: this occurs as a result of the removal of dialysable factor(s) responsible for the reduced cellular immune response in uraemia w16,17x. Evidence for a poor cellular immune response to TB amongst dialysis patients comes from a number of clinical studies that have shown a high frequency of anergy on skin testing w3,9,7,18±20x.
In common with others, we have shown that the presentation of peritoneal TB may be non-speci®c and similar to non-tuberculous bacterial peritonitis. Only two of our cases were smear-positive (one from peritoneal biopsy, one from PD¯uid), although six were culture-positive. In a population with unde®ned renal function and peritoneal TB, only 2% of ascitic taps were found to be smear-positive although 83% were culture-positive w21x. The results of mycobacterial culture may take several weeks, so a high index of suspicion is required to make this diagnosis, especially in patients from the Indian subcontinent. Peritoneal biopsy may be helpful, but treatment must sometimes be given on clinical grounds alone. Interestingly, whilst three of our patients were transferred to haemodialysis, most (®ve of eight) were able to continue with CAPDÐthus, removal of the dialysis catheter is not always necessary in this condition.
One solution to the problem of TB in dialysis patients may be to give anti-tuberculous chemoprophylaxis to all high-risk patients (e.g. those from certain ethnic groups) commencing CAPD or haemodialysis. Indeed, this has already been advocated by some workers, and treatment may only need to be given for 6±l2 months in total w6,10,22,23x.
In conclusion, peritoneal TB, an otherwise uncommon entity, is an important manifestation of TB in patients undergoing CAPD. It should always be considered when at-risk patients on CAPD develop peritonitis unresponsive to conventional antibiotics. In such patients, peritoneal¯uid should always be investigated for mycobacteria, and peritoneal biopsy considered.
